Bellicum Pharmaceuticals Price on March 31, 2023
BLCMDelisted Stock | USD 0.37 0.05 11.90% |
If you're considering investing in Bellicum Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bellicum Pharmaceuticals stands at 0.37, as last reported on the 28th of November, with the highest price reaching 0.44 and the lowest price hitting 0.37 during the day. We have found twenty-nine technical indicators for Bellicum Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Bellicum Pharmaceuticals' Risk Adjusted Performance of 0.0422, mean deviation of 12.36, and Downside Deviation of 16.04 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Bellicum Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Bellicum |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
BLCM |
Based on monthly moving average Bellicum Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellicum Pharmaceuticals by adding Bellicum Pharmaceuticals to a well-diversified portfolio.
Bellicum Pharmaceuticals Valuation on March 31, 2023
It is possible to determine the worth of Bellicum Pharmaceuticals on a given historical date. On March 31, 2023 Bellicum was worth 0.31 at the beginning of the trading date compared to the closed value of 0.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bellicum Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Bellicum Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bellicum Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bellicum Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
0.30 | 0.32 | 0.29 | 0.30 | 55,687 | |
03/31/2023 | 0.31 | 0.36 | 0.31 | 0.33 | 202,248 |
0.32 | 0.34 | 0.29 | 0.32 | 106,477 |
Backtest Bellicum Pharmaceuticals | | | Bellicum Pharmaceuticals History | | | Bellicum Pharmaceuticals Valuation | Previous | Next |
Bellicum Pharmaceuticals Trading Date Momentum on March 31, 2023
On April 03 2023 Bellicum Pharmaceuticals was traded for 0.32 at the closing time. The top price for the day was 0.34 and the lowest listed price was 0.29 . The trading volume for the day was 106.5 K. The trading history from April 3, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.03% . The overall trading delta against the current closing price is 9.09% . |
Bellicum Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Bellicum Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bellicum Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bellicum financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bellicum Pharmaceuticals Pink Sheet history
Bellicum Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bellicum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bellicum Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bellicum Pharmaceuticals stock prices may prove useful in developing a viable investing in Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas. Bellicum Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.
Bellicum Pharmaceuticals Pink Sheet Technical Analysis
Bellicum Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Bellicum Pharmaceuticals Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Bellicum Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bellicum Pharmaceuticals November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Bellicum Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bellicum Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Bellicum Pharmaceuticals pink sheet market strength indicators, traders can identify Bellicum Pharmaceuticals entry and exit signals to maximize returns
Bellicum Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bellicum Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Bellicum Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bellicum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0422 | |||
Jensen Alpha | 1.06 | |||
Total Risk Alpha | (2.88) | |||
Sortino Ratio | 0.0621 | |||
Treynor Ratio | 2.53 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Bellicum Pink Sheet
If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world |